This approach was designed to capture a wide variety of Env-specific B cells that were activated and selected for survival during the first 7 months of HIV-1 infection, and had the capacity to contribute to the plasma nAb and ADCC functions observed at this time point (Figure 1B). The gene discussed is ERVW-1; the disease is HIV-1 infection.